Collegium Pharmaceutical (COLL) Return on Equity (2017 - 2025)
Historic Return on Equity for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 0.23%.
- Collegium Pharmaceutical's Return on Equity fell 1600.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.2% for FY2024, which is 400.0% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Return on Equity stood at 0.23% for Q3 2025, which was down 1600.0% from 0.16% recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Return on Equity ranged from a high of 0.5% in Q2 2021 and a low of 0.22% during Q3 2022
- For the 5-year period, Collegium Pharmaceutical's Return on Equity averaged around 0.18%, with its median value being 0.23% (2025).
- In the last 5 years, Collegium Pharmaceutical's Return on Equity plummeted by -6800bps in 2022 and then soared by 6000bps in 2024.
- Collegium Pharmaceutical's Return on Equity (Quarter) stood at 0.32% in 2021, then crashed by -140bps to 0.13% in 2022, then soared by 302bps to 0.26% in 2023, then increased by 16bps to 0.3% in 2024, then fell by -23bps to 0.23% in 2025.
- Its last three reported values are 0.23% in Q3 2025, 0.16% for Q2 2025, and 0.19% during Q1 2025.